Back
Integra Lifesciences Holdings 10K Form
Sell
37
IART
Integra Lifesciences Holdings
Last Price:
23.04
Seasonality Move:
5.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-25 | 10Q | IART/Integra Lifesciences Holdings Quarterly |
| 2023-07-27 | 10Q | IART/Integra Lifesciences Holdings Quarterly |
| 2023-04-26 | 10Q | IART/Integra Lifesciences Holdings Quarterly |
| 2022-10-26 | 10Q | IART/Integra Lifesciences Holdings Quarterly |
| 2022-07-27 | 10Q | IART/Integra Lifesciences Holdings Quarterly |
| 2022-04-27 | 10Q | IART/Integra Lifesciences Holdings Quarterly |
Receive IART News And Ratings
See the #1 stock for the next 7 days that we like better than IART
IART Financial Statistics
Sales & Book Value
| Annual Sales: | $1.54B |
|---|---|
| Cash Flow: | $34.22M |
| Price / Cash Flow: | 31.75 |
| Annual Sales: | $20.31 |
| Price / Book: | 1.43 |
Profitability
| EPS (TTM): | 0.83000 |
|---|---|
| Net Income (TTM): | $67.74M |
| Gross Margin: | $884.74M |
| Return on Equity: | 4.07% |
| Return on Assets: | 1.79% |
Integra Lifesciences Holdings Earnings Forecast
Key Integra Lifesciences Holdings Financial Ratios
- The Gross Profit Margin over the past 29 years for IART is 57.39%.
- The Selling, General & Administrative Expenses for IART have been equal to 42.60% of Gross Profit Margin.
- The Research & Development expenses have been 6.76% of Revenue.
- The Interest Expense is 75.84% of Operating Income.
- The Net Earning history of IART is 4.39% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 15 years.
Integra Lifesciences Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | IART |
| CUSIP: | 457985 |
| Website: | integralife.com |
Debt
| Debt-to-Equity Ratio: | 0.94 |
|---|---|
| Current Ratio: | 3.45 |
| Quick Ratio: | 1.85 |
Price-to-Earnings
| Trailing P/E Ratio: | 34.39 |
|---|---|
| Forward P/E Ratio: | 8 |
IART Technical Analysis vs Fundamental Analysis
Sell
37
Integra Lifesciences Holdings (IART)
is a Sell
Is Integra Lifesciences Holdings a Buy or a Sell?
-
Integra Lifesciences Holdings stock is rated a Sell
The current Integra Lifesciences Holdings [IART] share price is $28.89. The Score for IART is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.